Bacteriemia de presunta fuente urinaria en adultos hospitalizados con bacteriuria asintomática
¿Tratar o no tratar? | Bacteriuria asintomática en adultos hospitalizados Read More »
The court’s controversial decision raises the bar for healthcare regulators when they’re implementing laws with undefined terms — and opens the door for stakeholders in the industry to sue when they’re unhappy with an agency’s reading of statute.
SCOTUS strikes down Chevron doctrine, curbing federal agency power Read More »
The telehealth vendor’s stock price has declined significantly since 2020. It received a warning this spring that its stock was trading below minimum standards, and could be removed from trading.
Amwell to implement reverse stock split to avoid delisting Read More »
The agency said which trials need diversity action plans and presented the timeline for implementing the requirement.
FDA shares draft guidance on clinical trial diversity action plans Read More »
The UnitedHealth pharmacy benefit manager did not have to admit guilt as part of the settlement, which amounts to a minuscule fraction of its annual revenue.
Optum Rx reaches $20M settlement with Justice Department over opioid prescribing Read More »
Steward has been gunning for the deal since March. Without Optum at the table, it’s unclear who will buy the struggling health system’s medical clinics.
Optum backs out of deal to buy Steward’s physician group Read More »
Patients could be diagnosed and potentially receive treatment at the same healthcare visit.
Cepheid wins FDA nod for fingerstick hepatitis C test Read More »
La criptomonedas, se han posicionado en el mercado, gracias a su sistema de seguridad y descentralización que conlleva a menos riesgos. Las economías inestables a nivel mundial han hallado en este sistema de critodivisas una forma de proteger su capital, de all&iacut …
The reorganization could create a new source of potential customers for primary care chain One Medical.
Amazon folds telehealth marketplace into One Medical Read More »
The global artificial intelligence (AI) in drug discovery market was evaluated at US$ 1.70 billion in 2023 and is expected to attain around US$ 11.93 billion by 2033, growing at a CAGR of 21.5% from 2024 to 2033.
AI In Drug Discovery Market Size to Expand US$ 11.93 Bn by 2033 Read More »
